To evaluate and compare the effects of single intravitreal injection of ranibizumab and bevacizumab on central retinal and choroidal thickness in patients with neovascular age-related macular degeneration (AMD).
Methods
Forty eyes of 40 patients with neovascular AMD that underwent intravitreal injection of vascular endothelial growth factor inhibitors (anti-VEGFs) were included. Patients were randomized into 2 groups: 20 eyes received ranibizumab and 20 eyes received bevacizumab injection. Central retinal and choroidal thicknesses of all eyes at baseline and 1 month postinjection scans were measured with Fourier-domain optical coherence tomography (OCT). Student t test and Mann-Whitney U test were used to compare the data.
Results
The mean central retinal thickness (CRT) showed significant decrease after single injection of ranibizumab (from 345.0 μm to 253.5 μm, p<0.01) and bevacizumab (from 329.5 μm to 251.0 μm, p<0.01) at the first month, respectively. There was no significant difference regarding the CRT change between groups (p = 0.39). The mean choroidal thickness decreased from 158.6 μm (115-317) to 155.5 μm (111-322) in the ranibizumab group and from 211.5 μm (143-284) to 201.5 μm (93-338) in bevacizumab group. The decrease was not significant between groups (p = 0.35).
Conclusions
Intravitreal injection of both ranibizumab and bevacizumab provided a significant decrease in CRT; however, the agents caused no significant change in choroidal thickness. Additionally, no difference between ranibizumab versus bevacizumab was observed related to macular edema inhibition.
HoV.Y.YehS.OlsenT.W.Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors. Am J Ophthalmol2013; 156: 23–28.
4.
RosenfeldP.J.BrownD.M.HeierJ.S.; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med2006; 355: 1419–31.
5.
KaiserP.K.BlodiB.A.ShapiroH.AcharyaN.R.; MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology2007; 114: 1868–75.
6.
SaddaS.R.StollerG.BoyerD.S.BlodiB.A.ShapiroH.IanchulevT.Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study. Retina2010; 30: 1390–9.
BashshurZ.F.HaddadZ.A.SchakalA.JaafarR.F.SaabM.NoureddinB.N.Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. Am J Ophthalmol2008; 145: 249–56.
9.
ChenC.Y.WongT.Y.HeriotW.J.Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study. Am J Ophthalmol2007; 143: 510–2.
10.
MartinD.F.MaguireM.G.YingG.S.GrunwaldJ.E.FineS.L.JaffeG.J.; CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med2011; 364: 1897–908.
11.
Comparison of Age-related macular degeneration Treatment Trials (CATT) Research Group. MartinD.F.MaguireM.G.FineS.L.Ranibizumab and bevacizumab for treatment of neovascular age related macular degeneration: two year results. Ophthalmology2012; 119: 1388–98.
12.
ChakravarthyU.HardingS.P.RogersC.A.; IVAN Study Investigators. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology2012; 119: 1399–411.
13.
ManjunathV.GorenJ.FujimotoJ.G.DukerJ.S.Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol2011; 152: 663–8.
14.
WoodA.BinnsA.MargrainT.Retinal and choroidal thickness in early age-related macular degeneration. Am J Ophthalmol2011; 152: 1030–8.
15.
BonninP.PournarasJ.A.C.LazrakZ.Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin®) in neovascular age-related macular degeneration. Acta Ophthalmol2010; 88: 641–5.
16.
PapadopoulouD.N.MendrinosE.MangiorisG.DonatiG.PournarasC.J.Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology2009; 116: 1755–61.
17.
ManjunathV.TahaM.FujimotoJ.G.DukerJ.S.Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol2010; 150: 325–9.
18.
BranchiniL.RegatieriC.V.Flores-MorenoI.BaumannB.FujimotoJ.G.DukerJ.S.Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology2012; 119: 119–23.
19.
FujiwaraT.ImamuraY.MargolisR.SlakterJ.S.SpaideR.F.Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol2009; 148: 445–50.
IkunoY.TanoY.Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci2009; 50: 3876–80.
22.
YeohJ.RahmanW.ChenF.Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography. Graefes Arch Clin Exp Ophthalmol2010; 248: 1719–28.
23.
SpaideR F.Age-related choroidal atrophy. Am J Ophthalmol2009; 147: 801–10.
24.
ImamuraY.FujiwaraT.MargolisR.SpaideR F.Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina2009; 29: 1469–73.
25.
MarukoI.IidaT.SuganoY.OjimaA.OgasawaraM.SpaideR.F.Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology2010; 117: 1792–9.
26.
MarukoI.IidaT.SuganoY.Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina2011; 31: 510–7.
27.
HirookaK.TenkumoK.FujiwaraA.BabaT.SatoS.ShiragaF.Evaluation of peripapillary choroidal thickness in patients with normal-tension glaucoma. BMC Ophthalmol2012; 12: 29.
28.
VanceS.K.ImamuraY.FreundK.B.The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina2011; 31: 332–5.
29.
TanC.S.OuyangY.RuizH.SaddaS.R.Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci2012; 53: 261–6.
30.
FitzgeraldM.E.WildsoetC.F.ReinerA.Temporal relationship of choroidal blood flow and thickness changes during recovery from form deprivation myopia in chicks. Exp Eye Res2002; 74: 561–70.
31.
KimD.Y.SilvermanR.H.ChanR.V.Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra®). Acta Ophthalmol2013; 91: 183–8.
32.
SogawaK.NagaokaT.TakahashiA.Relationship between choroidal thickness and choroidal circulation in healthy young subjects. Am J Ophthalmol2012; 153: 1129–32.
33.
HarrisA.ChungH.S.CiullaT.A.KagemannL.Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res1999; 18: 669–87.
34.
CiullaT.A.HarrisA.ChungH.S.Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol1999; 128: 75–80.
35.
ChungS.E.KangS.W.LeeJ.H.KimY.T.Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology2011; 118: 840–5.
NgE.W.AdamisA.P.Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol2005; 40: 352–68.
38.
StorkebaumE.CarmelietP.VEGF: a critical player in neurodegeneration. J Clin Invest2004; 113: 14–8.
39.
TiltonR.G.ChangK.C.LeJeuneW.S.StephanC.C.BrockT.A.WilliamsonJ.R.Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Invest Ophthalmol Vis Sci1999; 40: 689–96.
40.
EllabbanA.A.TsujikawaA.OginoK.Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization. Clin Ophthalmol2012; 6: 837–44.
41.
YamazakiT.KoizumiH.YamagishiT.KinoshitaS.Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. Ophthalmology2012; 119: 1621–7.
42.
MargolisR.SpaideR.F.A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol2009; 147: 811–5.
